Scutellaria lateriflora: Maiz-Tome, L.

Author(s):  
2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Inga Kwiecień ◽  
Beata Kawka ◽  
Halina Ekiert

American skullcap (Scutellaria lateriflora L.) has long been used as a medicine by North American Indian tribes. A monograph of Scutellariae lateriflorae herba was included in the American Herbal Pharmacopoeia in 2009. This raw material is very popular in North America because of its sedative action. It is also highly valued in Australia, while in Europe, it has been widely used until now in the United Kingdom. The main components of the herb of this plant species include flavonoids specific for the Scutellaria genus, mostly baicalein, baicalin, wogonin, scutellarin. They are accompanied by other groups of compounds: diterpenoids – neoclerodan derivatives, γ-aminobutyric acid, melatonin, serotonin, catalpol, phenolic acids, phenylpropanoid glycosides (mostly verbascoside) and essential oil. Studies of chemical composition and investigation of medicinal activity of this raw material confirmed its uses known from North American folk medicine. Study results proved most of all a significance of flavonoid compounds present in the raw material for its documented biological activity. The aim of the paper is to review the present knowledge on chemical composition and medicinal significance of this very valuable plant. The research team from the Department of Pharmaceutical Botany JU MC initiated biotechnological studies of this species. Its microshoots successfully grown in vitro produce considerable amounts of specific flavonoids (mostly baicalin and wogonoside) and verbascoside, and in future they can be an alternative rich source of these compounds for pharmaceutical and cosmetic applications.


Author(s):  
Madhukar Lohani ◽  
Mansi Patel ◽  
Mohammed Majrashi ◽  
Sneha Joshi ◽  
Barbara Kemppainen ◽  
...  

2012 ◽  
Vol 34 (9) ◽  
pp. 1757-1763 ◽  
Author(s):  
Agata Wilczańska-Barska ◽  
Aleksandra Królicka ◽  
Daniel Głód ◽  
Magdalena Majdan ◽  
Anna Kawiak ◽  
...  

1979 ◽  
Vol 42 (2) ◽  
pp. 228-230 ◽  
Author(s):  
M. S. Yaghmai ◽  
G. G. Benson

Planta Medica ◽  
2009 ◽  
Vol 75 (04) ◽  
Author(s):  
J Li ◽  
Y Ding ◽  
XC Li ◽  
D Ferreira ◽  
IA Khan

2015 ◽  
Vol 39 (9) ◽  
pp. 1240-1249 ◽  
Author(s):  
Santosh Shiwakoti ◽  
Dennis A. Shannon ◽  
C. Wesley Wood ◽  
Nirmal Joshee ◽  
Agnes Rimando ◽  
...  

Phytomedicine ◽  
2009 ◽  
Vol 16 (5) ◽  
pp. 485-493 ◽  
Author(s):  
Zhizhen Zhang ◽  
Xiao-yuan Lian ◽  
Shiyou Li ◽  
Janet L. Stringer

2012 ◽  
Vol 7 (4) ◽  
pp. 1934578X1200700 ◽  
Author(s):  
Minpei Kuroda ◽  
Katsura Iwabuchi ◽  
Yoshihiro Mimaki

MeOH extracts of 37 herbs were tested in screening experiments for rat intestinal α-glucosidase. The MeOH extract of the aerial parts of Scutellaria lateriflora L. (Lamiaceae) significantly inhibited sucrase and maltase activities, using sucrose and maltase as the substrates. Enzyme inhibition guided-fractionation of the MeOH extract of S lateriflora resulted in the isolation of a new diterpene glucoside, deacetylajugarin-IV 18- O-β-D-glucopyranoside (1), along with 20 known phenolics (2-21). The structures of 1-21 were elucidated on the basis of MS and NMR data analyses. Baicalein (4) and baicalin (10), a glycoside of 4, showed moderate sucrase inhibitory activities at IC50 values of 14.9 and 36.3 μM, respectively, whereas luteolin (3), acteoside (16), leucosceptoside A (18), and isoacteoside (20) showed weak inhibitory activities at IC50 values of 811, 522, 727, and 443 μM, respectively. This is the first report on mammalian α-glucosidase inhibitory activities of S lateriflora extract and identification of the constituents responsible for the activities. Apigenin (2), luteolin (3), 6-methoxyluteolin 4'-methyl ether (6), isoscutellarin 8- O-β-D-glucuronide (7), luteolin 7- O-β-D-glucuronide (9), wogonin 7- O-β-D-glucuronide methyl ester (12), eriodictyol (13), naringenin (14), naringenin 7- O-β-D-glucuronide (15), jionoside D (17), leucosceptoside A (18), and (+)-syringaresinol 4'- O-β-D-glucopyranoside (21) were isolated from this plant for the first time. The inhibitory properties of S lateriflora extract against α-glucosidase provide a prospect for its antidiabetic usage.


Sign in / Sign up

Export Citation Format

Share Document